;PMID: 7188249
;source_file_2948.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..28] = [t:0..28]
;1)sentence:[e:34..178] = [t:34..178]
;2)section:[e:182..230] = [t:182..230]
;3)sentence:[e:234..364] = [t:234..364]
;4)sentence:[e:365..499] = [t:365..499]
;5)sentence:[e:500..593] = [t:500..593]
;6)sentence:[e:594..759] = [t:594..759]
;7)sentence:[e:760..911] = [t:760..911]
;8)sentence:[e:912..991] = [t:912..991]
;9)sentence:[e:992..1093] = [t:992..1093]
;10)sentence:[e:1094..1301] = [t:1094..1301]
;11)sentence:[e:1302..1463] = [t:1302..1463]
;12)section:[e:1467..1511] = [t:1467..1511]

;section 0 Span:0..28
;EMBO J.  1982;1(10):1239-44.
(SEC
  (FRAG (NN:[0..4] EMBO) (NNP:[5..7] J.) (CD:[9..13] 1982) (.:[13..15] ;1)
        (-LRB-:[15..16] -LRB-) (CD:[16..18] 10) (-RRB-:[18..19] -RRB-)
        (::[19..20] :) (CD:[20..24] 1239) (HYPH:[24..25] -) (CD:[25..27] 44)
        (.:[27..28] .)))

;sentence 1 Span:34..178
;Tissue- and developmental stage-specific forms of a neural cell surface
;antigen  linked to differences in glycosylation of a common polypeptide.
(SENT
  (NP-HLN
    (NP
      (NP
        (NP
          (ADJP (NN:[34..40] Tissue) (HYPH:[40..41] -)
            (ADJP-1 (-NONE-:[41..41] *P*)))
          (NML-2 (-NONE-:[41..41] *P*)))
        (CC:[42..45] and)
        (NP
          (ADJP
            (NML (JJ:[46..59] developmental) (NN:[60..65] stage))
            (HYPH:[65..66] -)
            (ADJP-1 (JJ:[66..74] specific)))
          (NML-2 (NNS:[75..80] forms))))
      (PP (IN:[81..83] of)
        (NP (DT:[84..85] a) (JJ:[86..92] neural) (NN:[93..97] cell)
            (NN:[98..105] surface) (NN:[106..113] antigen))))
    (VP (VBN:[115..121] linked)
      (NP (-NONE-:[121..121] *))
      (PP-CLR (TO:[122..124] to)
        (NP
          (NP (NNS:[125..136] differences))
          (PP (IN:[137..139] in)
            (NP
              (NP (NN:[140..153] glycosylation))
              (PP (IN:[154..156] of)
                (NP (DT:[157..158] a) (JJ:[159..165] common)
                    (NN:[166..177] polypeptide))))))))
    (.:[177..178] .)))

;section 2 Span:182..230
;Rougon G, Deagostini-Bazin H, Hirn M, Goridis C.
(SEC
  (FRAG (NNP:[182..188] Rougon) (NNP:[189..190] G) (,:[190..191] ,)
        (NNP:[192..203] Deagostini-) (NNP:[203..208] Bazin) (NNP:[209..211] H,)
        (NNP:[212..216] Hirn) (NNP:[217..219] M,) (NNP:[220..227] Goridis)
        (NNP:[228..230] C.)))

;sentence 3 Span:234..364
;We have previously identified a cell surface glycoprotein of the mouse
;nervous  system named brain cell surface protein-2 (BSP-2).
;[327..355]:gene-protein:"brain cell surface protein-2"
;[357..362]:gene-protein:"BSP-2"
(SENT
  (S
    (NP-SBJ (PRP:[234..236] We))
    (VP (VBP:[237..241] have)
      (ADVP-TMP (RB:[242..252] previously))
      (VP (VBN:[253..263] identified)
        (NP
          (NP
            (NP (DT:[264..265] a)
              (NML (NN:[266..270] cell) (NN:[271..278] surface))
              (NN:[279..291] glycoprotein))
            (PP (IN:[292..294] of)
              (NP (DT:[295..298] the) (NN:[299..304] mouse)
                  (JJ:[305..312] nervous) (NN:[314..320] system))))
          (VP (VBN:[321..326] named)
            (NP (-NONE-:[326..326] *))
            (NP
              (NP (NN:[327..332] brain) (NN:[333..337] cell)
                  (NN:[338..345] surface) (NN:[346..355] protein-2))
              (NP (-LRB-:[356..357] -LRB-) (NN:[357..362] BSP-2)
                  (-RRB-:[362..363] -RRB-)))))))
    (.:[363..364] .)))

;sentence 4 Span:365..499
;Here we report that this  antigen is not a single, discrete entity, but a
;family of antigenically and  structurally related molecules.
(SENT
  (S
    (ADVP (RB:[365..369] Here))
    (NP-SBJ (PRP:[370..372] we))
    (VP (VBP:[373..379] report)
      (SBAR (IN:[380..384] that)
        (S
          (NP-SBJ (DT:[385..389] this) (NN:[391..398] antigen))
          (VP
            (VP (VBZ:[399..401] is)
              (ADVP=2 (RB:[402..405] not))
              (NP-PRD=1 (DT:[406..407] a) (JJ:[408..414] single)
                        (,:[414..415] ,) (JJ:[416..424] discrete)
                        (NN:[425..431] entity)))
            (,:[431..432] ,) (CC:[433..436] but)
            (VP
              (ADVP=2 (-NONE-:[436..436] *NOT*))
              (NP-PRD=1
                (NP (DT:[437..438] a) (NN:[439..445] family))
                (PP (IN:[446..448] of)
                  (NP
                    (ADJP
                      (ADVP (RB:[449..462] antigenically) (CC:[463..466] and)
                            (RB:[468..480] structurally))
                      (VBN:[481..488] related))
                    (NNS:[489..498] molecules)))))))))
    (.:[498..499] .)))

;sentence 5 Span:500..593
;Three components of 180, 140, and 120 K were  characteristic for more mature
;nervous tissues.
(SENT
  (S
    (NP-SBJ
      (NP (CD:[500..505] Three) (NNS:[506..516] components))
      (PP (IN:[517..519] of)
        (NP
          (NP (CD:[520..523] 180)
            (NML-1 (-NONE-:[523..523] *P*)))
          (,:[523..524] ,)
          (NP (CD:[525..528] 140)
            (NML-1 (-NONE-:[528..528] *P*)))
          (,:[528..529] ,) (CC:[530..533] and)
          (NP (CD:[534..537] 120)
            (NML-1 (NN:[538..539] K))))))
    (VP (VBD:[540..544] were)
      (ADJP-PRD (JJ:[546..560] characteristic)
        (PP (IN:[561..564] for)
          (NP
            (ADJP (RBR:[565..569] more) (JJ:[570..576] mature))
            (JJ:[577..584] nervous) (NNS:[585..592] tissues)))))
    (.:[592..593] .)))

;sentence 6 Span:594..759
;Adult cerebral cortex contained  the 140-K and 120-K antigens, adult spinal
;cord only the 120-K, and dorsal root  ganglia from young mice mainly the
;180-K component.
(SENT
  (S
    (S
      (NP-SBJ=3 (JJ:[594..599] Adult) (JJ:[600..608] cerebral)
                (NN:[609..615] cortex))
      (VP (VBD:[616..625] contained)
        (NP=2 (DT:[627..630] the)
          (NML
            (NML
              (NML (CD:[631..634] 140) (HYPH:[634..635] -) (NN:[635..636] K))
              (NML-1 (-NONE-:[636..636] *P*)))
            (CC:[637..640] and)
            (NML
              (NML (CD:[641..644] 120) (HYPH:[644..645] -) (NN:[645..646] K))
              (NML-1 (NNS:[647..655] antigens)))))))
    (,:[655..656] ,)
    (S
      (NP-SBJ=3 (JJ:[657..662] adult) (JJ:[663..669] spinal)
                (NN:[670..674] cord))
      (VP
        (NP=2 (RB:[675..679] only) (DT:[680..683] the)
          (NML (CD:[684..687] 120) (HYPH:[687..688] -) (NN:[688..689] K))
          (NML-1 (-NONE-:[689..689] *P*)))))
    (,:[689..690] ,) (CC:[691..694] and)
    (S
      (NP-SBJ=3
        (NP (JJ:[695..701] dorsal) (NN:[702..706] root) (NNS:[708..715] ganglia))
        (PP (IN:[716..720] from)
          (NP (JJ:[721..726] young) (NNS:[727..731] mice))))
      (VP
        (NP=2
          (ADVP (RB:[732..738] mainly))
          (DT:[739..742] the)
          (NML (CD:[743..746] 180) (HYPH:[746..747] -) (NN:[747..748] K))
          (NN:[749..758] component))))
    (.:[758..759] .)))

;sentence 7 Span:760..911
;Very different forms of the  antigen that migrated as a diffuse zone from
;180-250-K in SDS-polyacrylamide  gels were found in immature nervous
;tissues.
(SENT
  (S
    (NP-SBJ-2
      (NP (RB:[760..764] Very) (JJ:[765..774] different) (NNS:[775..780] forms))
      (PP (IN:[781..783] of)
        (NP
          (NP (DT:[784..787] the) (NN:[789..796] antigen))
          (SBAR
            (WHNP-1 (WDT:[797..801] that))
            (S
              (NP-SBJ-1 (-NONE-:[801..801] *T*))
              (VP (VBD:[802..810] migrated)
                (PP (IN:[811..813] as)
                  (NP
                    (NP (DT:[814..815] a) (JJ:[816..823] diffuse)
                        (NN:[824..828] zone))
                    (PP (IN:[829..833] from)
                      (NP
                        (QP (CD:[834..837] 180) (HYPH:[837..838] -)
                            (CD:[838..841] 250))
                        (HYPH:[841..842] -) (NN:[842..843] K)))))
                (PP-LOC (IN:[844..846] in)
                  (NP (NN:[847..865] SDS-polyacrylamide) (NNS:[867..871] gels)))))))))
    (VP (VBD:[872..876] were)
      (VP (VBN:[877..882] found)
        (NP-2 (-NONE-:[882..882] *))
        (PP-LOC (IN:[883..885] in)
          (NP (JJ:[886..894] immature) (JJ:[895..902] nervous)
              (NNS:[903..910] tissues)))))
    (.:[910..911] .)))

;sentence 8 Span:912..991
;A molecule different from the  previous ones was found in a neuroblastoma
;line.
;[972..985]:malignancy-type:"neuroblastoma"
(SENT
  (S
    (NP-SBJ-1
      (NP (DT:[912..913] A) (NN:[914..922] molecule))
      (ADJP (JJ:[923..932] different)
        (PP (IN:[933..937] from)
          (NP (DT:[938..941] the) (JJ:[943..951] previous) (NNS:[952..956] ones)))))
    (VP (VBD:[957..960] was)
      (VP (VBN:[961..966] found)
        (NP-1 (-NONE-:[966..966] *))
        (PP (IN:[967..969] in)
          (NP (DT:[970..971] a) (NN:[972..985] neuroblastoma)
              (NN:[986..990] line)))))
    (.:[990..991] .)))

;sentence 9 Span:992..1093
;Evidence is presented that the  structural diversity of BSP-2 is due to
;differences in glycosylation.
;[1048..1053]:gene-protein:"BSP-2"
(SENT
  (S
    (NP-SBJ-1 (NN:[992..1000] Evidence))
    (VP (VBZ:[1001..1003] is)
      (VP (VBN:[1004..1013] presented)
        (NP-1 (-NONE-:[1013..1013] *))
        (SBAR (IN:[1014..1018] that)
          (S
            (NP-SBJ
              (NP (DT:[1019..1022] the) (JJ:[1024..1034] structural)
                  (NN:[1035..1044] diversity))
              (PP (IN:[1045..1047] of)
                (NP (NN:[1048..1053] BSP-2))))
            (VP (VBZ:[1054..1056] is)
              (PP-PRD (IN:[1057..1060] due)
                (PP (TO:[1061..1063] to)
                  (NP
                    (NP (NNS:[1064..1075] differences))
                    (PP (IN:[1076..1078] in)
                      (NP (NN:[1079..1092] glycosylation)))))))))))
    (.:[1092..1093] .)))

;sentence 10 Span:1094..1301
;This  result indicates that cell type- and developmental stage-specific
;glycoprotein  patterns previously found in the nervous system may in part be
;due to different  glycosylation of identical polypeptides.
(SENT
  (S
    (NP-SBJ (DT:[1094..1098] This) (NN:[1100..1106] result))
    (VP (VBZ:[1107..1116] indicates)
      (SBAR (IN:[1117..1121] that)
        (S
          (NP-SBJ
            (NP
              (NP
                (ADJP
                  (NML (NN:[1122..1126] cell) (NN:[1127..1131] type))
                  (HYPH:[1131..1132] -)
                  (ADJP-1 (-NONE-:[1132..1132] *P*)))
                (NML-2 (-NONE-:[1132..1132] *P*)))
              (CC:[1133..1136] and)
              (NP
                (ADJP
                  (NML (JJ:[1137..1150] developmental) (NN:[1151..1156] stage))
                  (HYPH:[1156..1157] -)
                  (ADJP-1 (JJ:[1157..1165] specific)))
                (NML-2 (NN:[1166..1178] glycoprotein)
                       (NNS:[1180..1188] patterns))))
            (VP
              (ADVP-TMP (RB:[1189..1199] previously))
              (VBN:[1200..1205] found)
              (NP (-NONE-:[1205..1205] *))
              (PP-LOC (IN:[1206..1208] in)
                (NP (DT:[1209..1212] the) (JJ:[1213..1220] nervous)
                    (NN:[1221..1227] system)))))
          (VP (MD:[1228..1231] may)
            (PP (IN:[1232..1234] in)
              (NP (NN:[1235..1239] part)))
            (VP (VB:[1240..1242] be)
              (PP-PRD (IN:[1243..1246] due)
                (PP (TO:[1247..1249] to)
                  (NP
                    (NP (JJ:[1250..1259] different)
                        (NN:[1261..1274] glycosylation))
                    (PP (IN:[1275..1277] of)
                      (NP (JJ:[1278..1287] identical)
                          (NNS:[1288..1300] polypeptides)))))))))))
    (.:[1300..1301] .)))

;sentence 11 Span:1302..1463
;The finding that a neural cell surface  protein may be glycosylated in
;different ways has important implications for the  generation of cell surface
;specificity.
(SENT
  (S
    (NP-SBJ (DT:[1302..1305] The) (NN:[1306..1313] finding)
      (SBAR (IN:[1314..1318] that)
        (S
          (NP-SBJ-1 (DT:[1319..1320] a) (JJ:[1321..1327] neural)
                    (NN:[1328..1332] cell) (NN:[1333..1340] surface)
                    (NN:[1342..1349] protein))
          (VP (MD:[1350..1353] may)
            (VP (VB:[1354..1356] be)
              (VP (VBN:[1357..1369] glycosylated)
                (NP-1 (-NONE-:[1369..1369] *))
                (PP (IN:[1370..1372] in)
                  (NP (JJ:[1373..1382] different) (NNS:[1383..1387] ways)))))))))
    (VP (VBZ:[1388..1391] has)
      (NP
        (NP (JJ:[1392..1401] important) (NNS:[1402..1414] implications))
        (PP (IN:[1415..1418] for)
          (NP
            (NP (DT:[1419..1422] the) (NN:[1424..1434] generation))
            (PP (IN:[1435..1437] of)
              (NP
                (NML (NN:[1438..1442] cell) (NN:[1443..1450] surface))
                (NN:[1451..1462] specificity)))))))
    (.:[1462..1463] .)))

;section 12 Span:1467..1511
;PMID: 7188249 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1467..1471] PMID) (::[1471..1472] :) (CD:[1473..1480] 7188249)
        (NN:[1481..1482] -LSB-) (NNP:[1482..1488] PubMed) (::[1489..1490] -)
        (NN:[1491..1498] indexed) (IN:[1499..1502] for)
        (NNP:[1503..1511] MEDLINE-RSB-)))
